Literature DB >> 22897161

Understanding the value of information from pediatric clinical research.

Wendy J Ungar1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22897161     DOI： 10.2165/11640510-000000000-00000

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  14 in total

1.  Survival distributions impact the power of randomized placebo-phase design and parallel groups randomized clinical trials.

Authors:  Lusine Abrahamyan; Chuan Silvia Li; Joseph Beyene; Andrew R Willan; Brian M Feldman
Journal:  J Clin Epidemiol       Date:  2010-10-06       Impact factor: 6.437

2.  Pediatric clinical trials registry.

Authors:  Maurizio Bonati; Chiara Pandolfini
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

3.  Comparative effectiveness research in Ontario, Canada: producing relevant and timely information for health care decision makers.

Authors:  Danielle M Whicher; Kalipso Chalkidou; Irfan A Dhalla; Leslie Levin; Sean Tunis
Journal:  Milbank Q       Date:  2009-09       Impact factor: 4.911

Review 4.  Drugs in pregnancy.

Authors:  G Koren; A Pastuszak; S Ito
Journal:  N Engl J Med       Date:  1998-04-16       Impact factor: 91.245

5.  Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.

Authors:  Martin Stanulla; Elke Schaeffeler; Thomas Flohr; Gunnar Cario; André Schrauder; Martin Zimmermann; Karl Welte; Wolf-Dieter Ludwig; Claus R Bartram; Ulrich M Zanger; Michel Eichelbaum; Martin Schrappe; Matthias Schwab
Journal:  JAMA       Date:  2005-03-23       Impact factor: 56.272

Review 6.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

7.  The Dutch Medicines for Children Research Network: a new resource for clinical trials.

Authors:  Elske H Weber; Ivo T F Timmermans; Martin Offringa
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

8.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

9.  Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency).

Authors:  Ettore Napoleone
Journal:  Ital J Pediatr       Date:  2011-01-19       Impact factor: 2.638

10.  Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations.

Authors:  Birka Lehmann
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-12-08       Impact factor: 3.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.